Global Vitamin B12 Immunoaffinity Column Market Growth 2025-2031

The global Vitamin B12 Immunoaffinity Column market size is predicted to grow from US$ 27.7 million in 2025 to US$ 42.7 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Vitamin B12 immunoaffinity column is an analytical tool specifically designed for the separation and enrichment of vitamin B12 in samples. Based on immunoaffinity technology, specific antibodies against vitamin B12 are chemically immobilized on a specific solid-phase carrier. The resulting affinity packing material is then filled into a column tube. When a sample solution containing vitamin B12 passes through the column, vitamin B12 specifically binds to the immobilized antibodies, while other impurities in the sample flow out with the solution. Subsequently, the vitamin B12 bound to the antibodies is eluted using a specific eluent, enabling the separation, enrichment and purification of vitamin B12 in the sample. This facilitates accurate quantitative analysis by methods such as high-performance liquid chromatography, and is commonly used in the detection of vitamin B12 content in fields like food, pharmaceuticals and biological samples.

United States market for Vitamin B12 Immunoaffinity Column is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Vitamin B12 Immunoaffinity Column is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Vitamin B12 Immunoaffinity Column is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Vitamin B12 Immunoaffinity Column players cover Gold Standard Diagnostics, R-Biopharm AG, CHROMATIFIC, Pribolab Biotech, Creative Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Vitamin B12 Immunoaffinity Column Industry Forecast” looks at past sales and reviews total world Vitamin B12 Immunoaffinity Column sales in 2024, providing a comprehensive analysis by region and market sector of projected Vitamin B12 Immunoaffinity Column sales for 2025 through 2031. With Vitamin B12 Immunoaffinity Column sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B12 Immunoaffinity Column industry.

This Insight Report provides a comprehensive analysis of the global Vitamin B12 Immunoaffinity Column landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B12 Immunoaffinity Column portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B12 Immunoaffinity Column market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B12 Immunoaffinity Column and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B12 Immunoaffinity Column.

This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B12 Immunoaffinity Column market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Agarose Gel Matrix
Polymer Matrix

Segmentation by Application:
Pharmaceuticals
Health Products
Food and Beverages
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gold Standard Diagnostics
R-Biopharm AG
CHROMATIFIC
Pribolab Biotech
Creative Diagnostics
Eagle Biosciences
BBI Solutions
BIOTICA
Romer Labs
Evergreen
Shandong Meizheng Bio-Tech
Anavo
Welch Materials
Dikma Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vitamin B12 Immunoaffinity Column market?

What factors are driving Vitamin B12 Immunoaffinity Column market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vitamin B12 Immunoaffinity Column market opportunities vary by end market size?

How does Vitamin B12 Immunoaffinity Column break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.